CRN Foundation Pledges to Fund Supplement Advertising Watchdog NAD through 2017


The NAD self-regulatory program for the dietary supplement industry will continue for at least another three years.

The Council for Responsible Nutrition Foundation (CRNF; Washington, DC) announced on Monday it has pledged grants to continue funding a program that monitors advertising for dietary supplements through 2017. Directed by the National Advertising Division (NAD), the self-regulatory program strives to notify companies of non-compliant advertising behavior so it can be voluntarily corrected before the FTC or other law enforcement agencies must become involved.

“Self-regulation is the hallmark of a mature industry, and our member companies proudly continue to support this self-regulatory initiative because we understand that truthful and accurate advertising levels the playing field for honest advertisers and ultimately serves the consumer,” said Steve Mister, CRNF president and CEO in a press release.

NAD’s dietary supplement program launched in 2006 and passed the milestone of completing more than 200 advertising challenges in June of 2014. With an attorney focused solely on the dietary supplement category, NAD reports 98% of challenges have been met with compliance by companies.

NAD monitors print, broadcast, infomercial, and web-based advertising to discover misleading, untruthful, or unsubstantiated claims worthy of a challenge. Each challenge results in a written decision explaining the review as well as guidance for future advertising if needed.

Mister encouraged all industry stakeholders to remain involved in the program by reporting any inaccurate or misleading advertising claims to the NAD by filing a competitive claim. Information on the program is available at

To date, CRNF has pledged more than $2.1 million to the program for monitoring dietary supplement advertising. NAD is a service of the Better Business Bureau.


Michael Crane
Associate Editor
Nutritional Outlook magazine


Photo ©

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.